← Back
$ACRV All transactions

Acrivon Therapeutics, Inc.

F

$ Value

$459

Shares

403

Price

$1

Filed

May 16

Insider

Name

Gamelin Erick

Title

Chief Development Officer

CIK

0001950551

Roles

Officer

Transaction Details

Transaction Date

2025-05-14

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

16,089

Footnotes

Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Filing Info

Accession No.

0000905148-25-001822

Form Type

4

Issuer CIK

0001781174

Gamelin Erick's History

Date Ticker Type Value
2025-08-14 ACRV F $560
2025-05-14 ACRV F $459

Other Insiders at ACRV (90d)

Insider Bought Sold Last
RA CAPITAL MANAGEMENT, L.P. 2026-04-22
Miller Mary
Chief Legal Officer
2026-04-17